2-210674926-G-A

Variant summary

Our verdict is Benign. Variant got -11 ACMG points: 2P and 13B. PM1BP4_StrongBP6BS1BS2

The NM_001875.5(CPS1):​c.4126G>A​(p.Gly1376Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0136 in 1,613,610 control chromosomes in the GnomAD database, including 205 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.013 ( 31 hom., cov: 33)
Exomes 𝑓: 0.014 ( 174 hom. )

Consequence

CPS1
NM_001875.5 missense

Scores

5
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:6

Conservation

PhyloP100: 4.38
Variant links:
Genes affected
CPS1 (HGNC:2323): (carbamoyl-phosphate synthase 1) The mitochondrial enzyme encoded by this gene catalyzes synthesis of carbamoyl phosphate from ammonia and bicarbonate. This reaction is the first committed step of the urea cycle, which is important in the removal of excess urea from cells. The encoded protein may also represent a core mitochondrial nucleoid protein. Three transcript variants encoding different isoforms have been found for this gene. The shortest isoform may not be localized to the mitochondrion. Mutations in this gene have been associated with carbamoyl phosphate synthetase deficiency, susceptibility to persistent pulmonary hypertension, and susceptibility to venoocclusive disease after bone marrow transplantation.[provided by RefSeq, May 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -11 ACMG points.

PM1
In a domain MGS-like (size 145) in uniprot entity CPSM_HUMAN there are 21 pathogenic changes around while only 1 benign (95%) in NM_001875.5
BP4
Computational evidence support a benign effect (MetaRNN=0.0067127645).
BP6
Variant 2-210674926-G-A is Benign according to our data. Variant chr2-210674926-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 258484.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Benign=5}. Variant chr2-210674926-G-A is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.0127 (1939/152234) while in subpopulation AMR AF= 0.0158 (242/15282). AF 95% confidence interval is 0.0148. There are 31 homozygotes in gnomad4. There are 984 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 31 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CPS1NM_001875.5 linkuse as main transcriptc.4126G>A p.Gly1376Ser missense_variant 35/38 ENST00000233072.10 NP_001866.2 P31327-1A0A024R454Q6PEK7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CPS1ENST00000233072.10 linkuse as main transcriptc.4126G>A p.Gly1376Ser missense_variant 35/381 NM_001875.5 ENSP00000233072.5 P31327-1

Frequencies

GnomAD3 genomes
AF:
0.0127
AC:
1936
AN:
152116
Hom.:
31
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00292
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0159
Gnomad ASJ
AF:
0.0354
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.00642
Gnomad FIN
AF:
0.0293
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.0156
Gnomad OTH
AF:
0.0172
GnomAD3 exomes
AF:
0.0131
AC:
3283
AN:
251254
Hom.:
42
AF XY:
0.0132
AC XY:
1794
AN XY:
135790
show subpopulations
Gnomad AFR exome
AF:
0.00258
Gnomad AMR exome
AF:
0.0109
Gnomad ASJ exome
AF:
0.0299
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.00425
Gnomad FIN exome
AF:
0.0313
Gnomad NFE exome
AF:
0.0141
Gnomad OTH exome
AF:
0.0245
GnomAD4 exome
AF:
0.0137
AC:
20051
AN:
1461376
Hom.:
174
Cov.:
29
AF XY:
0.0136
AC XY:
9875
AN XY:
727016
show subpopulations
Gnomad4 AFR exome
AF:
0.00263
Gnomad4 AMR exome
AF:
0.0125
Gnomad4 ASJ exome
AF:
0.0304
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00473
Gnomad4 FIN exome
AF:
0.0315
Gnomad4 NFE exome
AF:
0.0139
Gnomad4 OTH exome
AF:
0.0147
GnomAD4 genome
AF:
0.0127
AC:
1939
AN:
152234
Hom.:
31
Cov.:
33
AF XY:
0.0132
AC XY:
984
AN XY:
74438
show subpopulations
Gnomad4 AFR
AF:
0.00291
Gnomad4 AMR
AF:
0.0158
Gnomad4 ASJ
AF:
0.0354
Gnomad4 EAS
AF:
0.000386
Gnomad4 SAS
AF:
0.00664
Gnomad4 FIN
AF:
0.0293
Gnomad4 NFE
AF:
0.0156
Gnomad4 OTH
AF:
0.0170
Alfa
AF:
0.0147
Hom.:
25
Bravo
AF:
0.0108
TwinsUK
AF:
0.0138
AC:
51
ALSPAC
AF:
0.0153
AC:
59
ESP6500AA
AF:
0.00454
AC:
20
ESP6500EA
AF:
0.0164
AC:
141
ExAC
AF:
0.0118
AC:
1430
EpiCase
AF:
0.0175
EpiControl
AF:
0.0176

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:6
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Congenital hyperammonemia, type I Uncertain:1Benign:3
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Benign, no assertion criteria providedclinical testingNatera, Inc.Sep 16, 2020- -
Benign, criteria provided, single submitterclinical testingCenter for Genomic Medicine, King Faisal Specialist Hospital and Research CenterApr 04, 2024- -
not specified Benign:2
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingGeneDxMar 18, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenSep 01, 2024CPS1: BS1, BS2 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.087
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.35
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.20
.;T;.
Eigen
Benign
0.036
Eigen_PC
Uncertain
0.25
FATHMM_MKL
Uncertain
0.88
D
LIST_S2
Uncertain
0.88
D;D;D
MetaRNN
Benign
0.0067
T;T;T
MetaSVM
Benign
-0.64
T
MutationAssessor
Benign
0.57
.;N;.
PrimateAI
Uncertain
0.55
T
PROVEAN
Benign
0.64
N;N;N
REVEL
Benign
0.28
Sift
Benign
0.19
T;T;T
Sift4G
Benign
0.24
T;T;T
Polyphen
0.0070
.;B;.
Vest4
0.074
MPC
0.23
ClinPred
0.0090
T
GERP RS
5.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.40
gMVP
0.51

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs140578009; hg19: chr2-211539650; COSMIC: COSV51818882; API